Key facts
- It has raised $17.3M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Jolmo Investment, YuanBio Venture Capital, Leader Venture Capital, Huatai Zijin Investment, Hyview Group — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Biosurf
- ·The full record, as it builds
Funding rounds
No funding rounds for Biosurf are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biosurf
Manufacturer of medical functional coating solutions aims to drive innovation in interventional medical devices. The company's offerings feature hydrophilic lubricants, anticoagulants, antibacterial anti-crystallization and drug release coatings, along with automated coating equipment, analytical instruments, ODM services, and plating solutions, helping medical device manufacturers improve product performance, ensure regulatory compliance, and enable scalable production of advanced coated medical devices.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Website
- biosurf.cn/
- Ownership
- Privately Held (backing)
Biosurf doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biosurf shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biosurf in its N-PORT filings yet. We sweep new filings monthly.